期刊文献+

顺铂联合食管癌相关基因2蛋白对人食癌EC9706细胞的增殖抑制研究 被引量:7

Proliferation inhibition of cisplatin combined with esophageal cancer associated gene 2 protein on human cancer EC9706 cells
原文传递
导出
摘要 目的研究顺铂(DDP)联合食管癌相关基因2(ECRG2)蛋白对人食管癌EC9706细胞增殖抑制作用及诱导其凋亡的机制。方法将人食管癌EC9706细胞分为空白对照组、阳性对照组和低、中、高3个质量浓度实验组。阳性对照组细胞用3 mg·L^(-1)顺铂处理,低、中、高3个质量浓度实验组细胞在阳性对照组的基础上用质量浓度为5.5,7.5,9.5μg·L^(-1)的ECRG2蛋白处理,空白对照组细胞不做任何处理。检测各组细胞的活性和细胞凋亡率,用反转录-聚合酶链式反应(RT-PCR)法检测人食管癌EC9706细胞耐药基因的表达情况。结果空白对照组、阳性对照组和低、中、高3个质量浓度实验组人食管癌EC9706细胞活性分别为100.00%,(92.12±2.36)%,(88.62±3.22)%,(82.15±2.05)%,(78.41±2.16)%,阳性对照组和3个质量浓度实验组细胞活性显著低于空白对照组(P<0.05或P<0.01),中、高质量浓度实验组均显著低于阳性对照组(均P<0.05);且中、高质量浓度实验组细胞活性随ECRG2蛋白作用浓度增大逐渐降低(P<0.01)。阳性对照组和低、中、高3个质量浓度实验组人食管癌EC9706细胞凋亡率分别为(5.21±0.24)%,(11.45±0.66)%,(16.86±1.42)%,(22.62±2.12)%,均显著高于空白对照组的(2.89±0.32)%,低、中、高3个质量浓度实验组细胞凋亡率均明显高于阳性对照组(均P<0.01)。阳性对照组和低、中、高3个质量浓度实验组细胞谷胱甘肽巯基转移酶-π(GST-π)和多药耐药蛋白基因(MRP)mRNA相对表达量均低于空白对照组,且低、中、高3个质量浓度实验组低于阳性对照组(P<0.05或P<0.01)。结论顺铂可增强ECRG2蛋白对人食管癌EC9706细胞的增殖抑制作用,并可促进细胞凋亡,其机制可能与顺铂联合ECRG2显著降低GST-π和MRP基因表达有关。 Objective To investigate the inhibitory effect of cisplatin( DDP) combined with esophageal cancer associated gene 2( ECRG2)on the proliferation of human esophageal carcinoma EC9706 cells and its mechanism. Methods Human esophageal carcinoma EC9706 cells were divided into blank control group,positive control group and low,medium and high concentration experimental groups. Positive control group cells were treated with 3 mg · L^-1 cisplatin. The cells in low,medium and high concentration groups were treated with 5. 5,7. 5 and 9. 5 μg·L^-1 ECRG2,blank control group cells was given no treatment. The activity and apoptosis rate of cells in each group were detected, and theexpression of multi-drug resistance gene in human esophageal carcinoma cell line EC9706 was detected by reverse transcriptase-polymerase chain reaction( RT-PCR). Results The cell viability of EC9706 cells in control group,positive control group and low,medium and high concentration experimental groups were 100. 00%,( 92. 12 ± 2. 36) %,( 88. 62 ± 3. 22) % and( 82. 15 ± 2. 05) %,( 78. 41 ± 2. 16) %. The cell viability in positive control group and three experimental groups were significantly lower than that in blank control group( P〈0. 05 or P〈0. 01),and those in medium and high concentration groups were significantly lower than that in positive control group( P〈0. 05). The cell viability in medium and high concentration groups decreased with the increasing of ECRG2 protein concentration( P〈0. 01). The apoptotic rates of EC9706 cells in positive control group,low,medium and high concentration experimental groups were( 5. 21 ± 0. 24) %,( 11. 45 ± 0. 66) %,( 16. 86 ± 1. 42) % and( 22. 62 ± 2. 12) %,had significant difference with that in blank control group,which was( 2. 89 ± 0. 32) %. The apoptotic rates of low,medium and high concentration experimental groups were significantly higher than that in pos-itive control group( P〈0. 01). The relative expression levels of GS
作者 王锐 宋征宇
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2018年第4期446-449,共4页 The Chinese Journal of Clinical Pharmacology
关键词 食管癌 顺铂 食管癌相关基因2 增殖 凋亡 esophageal cancer cisplatin esophageal cancer related gene 2 proliferation apoptosis
  • 相关文献

参考文献4

二级参考文献20

  • 1Gui Y,Bi M,Su T.Molecular cloning and characterization of a novel esophageal cancer related gene[J].Int J Oncol,2010,37(6):1521-1528. 被引量:1
  • 2Tang CH,Wei Y.The urokinase receptor and integrins in cancer progression[J].Cell Mol Life Sci,2008,65(12):1916-1932. 被引量:1
  • 3Chapman HA,Wei Y.Protease crosstalk with integrins:the urokinase receptor paradigm[J].Thromb Haemost,2001,86:124-129. 被引量:1
  • 4Franco P,Vocca I,Carriero M,et al.Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase andαvβ5[J].J Cell Sci,2006,119(16):3424-3434. 被引量:1
  • 5Czekay RP,Aertgeerts K,Curriden SA,et al.Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins[J].J Cell Biol,2003,160(5):781-791. 被引量:1
  • 6Sitrin RG,Johnson RG,Pan PM,et al.Lipid raft compartmentalization of urokinase receptor signaling in human neutrophils[J].Am J Respir Cell Mol Biol,2004,30:233-241. 被引量:1
  • 7Ahmed N,Oliva K,Wang Y,et al.Downregulation of urokinase plasminogen activator receptor expression inhibits ERK signaling with concomitant suppression of invasiveness due to loss of u PAR-β1 integrin complex in colon cancer cells[J].Br J Cancer,2003,89:374-384. 被引量:1
  • 8Gondi CS,Kandhukuri N,Dinh DH,et al.Down-regulation of u PAR and u PA activates caspases-mediated apoptosis and inhibits the PI3K/AKT pathway[J].Int J Oncol,2007,31:19-27. 被引量:1
  • 9Resnati M,Pallavicini I,Wang JM.The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R[J].Proc Natl Acad Sci USA,2002,99(3):1359-1364. 被引量:1
  • 10Mazzieri R,D′Alessio S,Kenmoe RK,et al.An uncleavable u PAR mutant allows dissection of signaling pathways in u PA-dependent cell migration[J].Mol Biol Cell,2006,17:367-378. 被引量:1

共引文献9

同被引文献55

引证文献7

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部